V. K. Gupta, D. Pannu, M. P. Singh, and L. Kumar, “Effect of SGLT-2 inhibitor (remogliflozin) plus DPP4 inhibitor (vildagliptin) on diabetic nephropathy in patients with type 2 diabetes mellitus comparison with combination of metformin and sulphonylureas”, Int J Adv Med, vol. 10, no. 6, pp. 446–451, May 2023.